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Abstract 
Background: This paper tries to describe prevalence and patterns of antibiotics prescription and bacteria detection 
and sensitivity to antibiotics in rural China and implications for future antibiotic stewardship.
Methods: The study was implemented in one village clinic and one township health center in each of four rural resi-
dential areas in Anhui Province, China. It used mixed-methods comprising non-participative observations, exit-survey 
and microbiological study. Observations were conducted to record clinical diagnosis and antibiotic prescription. 
Semi-structured questionnaire survey was used to collect patient’s sociodemographic information and symptoms. 
Sputum and throat swabs were collected for bacterial culture and susceptibility testing.
Results: A total of 1068 (51.0% male vs 49.0% female) patients completed the study with diagnosis of respiratory 
tract infection (326,30.5%), bronchitis/tracheitis (249,23.3%), pharyngitis (119,11.1%) and others (374, 35.0%). They pro-
vided 683 sputum and 385 throat swab specimens. Antibiotics were prescribed for 88% of the RTI patients. Of all the 
specimens tested, 329 (31%) were isolated with bacteria. The most frequently detected bacteria were K. pneumonia 
(24% in all specimens), H. influenza (16%), H. parainfluenzae (15%), P. aeruginosa (6%), S.aureus (5%), M. catarrhalis (3%) 
and S. pneumoniae (2%).
Conclusions: The study establishes the feasibility of conducting microbiological testing outside Tier 2 and 3 hospitals 
in rural China. It reveals that prescription of antibiotics, especially broad-spectrum and combined antibiotics, is still 
very common and there is a clear need for stewardship programs aimed at both reducing the number of prescrip-
tions and promoting single and narrow-spectrum antibiotics.
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Background
Antimicrobial resistance (AMR) has become one of the 
biggest threats to global health [1, 2]. It leads to higher 
financial costs, prolonged hospital stays and increased 
patient mortality. Data from 76 countries including 
China show that global antibiotics consumption grew 
by more than 39% between 2000 and 2015 and China 
consumes the second largest amount of antibiotics in 
the world [3] with a prescription rate twice that recom-
mended by the World Health Organization (WHO). 
Rural areas have higher antibiotic prescribing rates than 
urban areas [4]. According to a survey in rural areas of 
Shandong and Ningxia, 89% and 77% of the prescriptions 
contained antibiotics for patients clinically diagnosed 
as having upper respiratory tract infections (RTIs) [5]. 
Another survey of prescriptions from village clinics in 
middle-east China showed that the proportion of antibi-
otics prescribed for RTIs accounted for 87% [6]. The Chi-
nese government has introduced a number of regulations 
to control antibiotic use in the last decade, but these have 
not played a significant role in rural areas [7].
The majority of people in China live in rural and town-
ship areas. Physicians in these areas mainly provide two 
kinds of services for residents, the treatment of common 
infectious diseases (mainly RTIs), and the management 
of chronic diseases. The excessive antibiotics prescrip-
tions mostly occur in treating common RTIs. A range 
of possible reasons for unnecessary use of antibiotics by 
rural and township physicians have been identified. It is 
not uncommon for them to prescribe antibiotics ‘just in 
case’, due to a desire to reduce medical, legal and reputa-
tion risk in the face of diagnostic uncertainty [8]. Antibi-
otics may also be used unnecessarily under the driver of 
income interests, including prescribing of inappropriate 
antibiotics for particular diseases, unnecessary escala-
tion (for example prescribing more expensive and broad-
spectrum antibiotics when cheaper and more specific 
antibiotics can give the same result) and intravenous use 
[9, 10]. In addition, most rural and township physicians 
in China have to distinguish bacterial or virus infection 
based on patient-reported symptoms because microbio-
logical facilities are not available at most front-line health 
care settings [11].
Most research on AMR in China has drawn on 
patient data collected in urban specialist hospitals. 
The often asserted high burden of AMR in China may 
be misleading since current assumptions are based on 
potential pathogens isolated in selected microbiology 
laboratories enrolled in the national surveillance system 
and it is uncertain if this reflects the incidence of resist-
ance in non-hospitalized patients with mild to moderate 
infection receiving antibiotics, most of whom do not have 
samples sent to the laboratory [12, 13]. UK data indicates 
that 1:35 patients presenting to their general practition-
ers with acute cough have microbiological sampling; 
while the same sample proportion is only about 1:5 at 
secondary and tertiary medical care settings [14]. These 
data indicate that resistance rates to key antibiotics based 
on biased laboratory data may be over-emphasized [15–
18]. Similarly, the often reported reduction in antibiotics 
prescription rate derived from paper or electronic medi-
cal records may also be misleading since such records in 
most primary clinics in China are incomplete or inac-
curate and the bulk of antibiotics is used at primary care 
settings.
This paper tries to describe prevalence and patterns 
of antibiotics prescription and bacteria detection and 
sensitivity to antibiotics in rural China and implica-
tions for future antibiotic stewardship. It uses data 
from a mixed methods project co-sponsored by China 
National Natural Science Foundation and UK Research 
and Innovation [14].
Methods
This study is part of the ‘pathways to optimizing antibiotic 
use in Anhui: identifying key determinants in community 
and clinical settings’ project. It used mixed-methods con-
sisting of qualitative interviews, non-particative obser-
vations, semi-structured surveys and microbiological 
studies. The study protocol has been published separately 
[14]. This paper used mainly the quantitative data from 
the study.
Setting
The study was implemented in one village clinic and one 
township health center in each of four rural residen-
tial areas in Anhui Province, China. Anhui Province is 
located in the middle east of China and has a population 
of 68.6 million of whom 57% live in rural areas. It has 968 
hospitals, 1,941 community and 1,398 township health 
centers, and 15,288 village clinics.
Participants
The study aimed to recruit 1,000 patients presenting with 
respiratory infection [14]. Inclusion criteria were male or 
female patients who were: a) 18  years or older and able 
to give consent to participate in the microbiological study 
and exit survey; b) presenting to the recruitment site for 
his/her current illness for the first time during the study 
period; and c) observed as having one or more of the fol-
lowing: exacerbation of chronic obstructive pulmonary 
disease (COPD), upper respiratory tract infection with 
productive cough or sore throat. Selection of these con-
ditions was based on the consideration that there may 
be differences between patients with different clinical 
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diagnosis (e.g., higher chances for identifying bacteria 
and antibiotics resistance among patients with exac-
erbation of COPD than those with cough and/or a sore 
throat). Acute otitis and rhinosinusitis were not included 
because these diseases happen mainly in children while 
this study population comprised only adults (over 
18-year-old).
Patients were selected via “consecutive sampling” 
in which, when a start date had been determined, the 
recruitment continued daily (7  days a week) thereaf-
ter, between 8am-5 pm or 9am- 6 pm on alternate days, 
until the target numbers had been reached. All incom-
ing patients to the site village clinics and township health 
centers who met the inclusion criteria during any study 
day were invited to participate. This was a pragmatic 
approach to sampling since patient record systems do not 
allow the flexibility to carry out random sampling, and 
ongoing recruitment ensured the most efficient use of 
staff and resources in this setting.
Data collection
Semi‑structured observations and exit surveys
A trained researcher was sent to each participating clin-
ics and health centers to perform semi-structured obser-
vations and exist survey. The observation focused on 
daily operational routine including test ordering, pre-
scribing, patient recall and other standard procedures 
using a pre-designed worksheet [14]. The exit survey 
used a questionnaire consisting of structured and semi-
structured questions informed by open-ended interviews 
undertaken in the study’s pilot phase and included infor-
mation on social demographics, symptoms and diseases 
history. The questionnaire was administered face-to-fact 
by the researcher for all patients consented by the attend-
ing clinicians at clinics and health centers and recruited 
into the study. The questionnaire was completed when 
the episode of care had concluded.
Specimen collection and microbiological testing
The study collected sputum and throat swabs for bac-
terial culture, identification and susceptibility testing. 
Sputum was collected from patients presenting with pro-
ductive cough and throat swabs from patients with sore 
throat. Samples were collected by the attending doctor 
using a sterilized container and according to a standard 
protocol. The specimens were transported and tested 
at the Central Laboratory of Anhui Medical University 
(AMU). For details of the test procedures, please refer to 
our published protocol [14].
Data process and analysis
Recordings from the semi-structured observations 
were examined to see whether and which antibiotics 
were prescribed for the symptomatic RTI patients. Two 
researchers performed the examination independently 
and discordances were solved by discussions between 
them. For data from the semi-structured exit-survey, only 
the structured items were used in this study. This paper 
reports on descriptive analysis of: a) social demographics 
(sex, age and educations) of patients recruited; b) antibi-
otics use by clinical diagnosis; c) percentages of patients 
identified with specific types of bacteria by groups of 
clinical diagnosis; and d) prevalence rates of resistance 




A total of 1073 patients meeting our inclusion criteria 
were invited to participate and 1068 (51% males and 49% 
females) provided specimens and completed the face-to-
face survey. Of these, 683 provided sputum and 385 pro-
vided throat swab specimens. Over 60% of their visits to 
the clinics or health centers happened within 4 days after 
onset of infection symptoms and the mean time interval 
was 6 days. Over half (55%) of the patients had less than 
5 years of education with 26% being illiterate. There were 
statistically significant differences between sex groups 
with males being older and more educated (Table 1).
Clinical diagnosis and antibiotic use
Antibiotics were prescribed for 88% of all recruited 
patients and 36% of these prescriptions contained two or 
Table 1 Socio-demographic characteristics of respondents
Type of specimens Total
Sputum Throat swab
Age
   <  = 39 124 (18.2) 148 (38.4) 272 (25.5)
  40–53 168 (24.6) 114 (29.6) 282 (26.4)
  54–64 183 (26.8) 69 (17.9) 252 (23.6)
   >  = 65 208 (30.5) 52 (13.5) 260 (24.3)
  Missing 0 (0.0) 2 (0.5) 2 (0.2)
Education
  0 211 (30.9) 65 (16.9) 276 (25.8)
  1–5 211 (30.9) 95 (24.7) 306 (28.7)
  6–8 121 (17.7) 108 (28.1) 229 (21.4)
   > 8 134 (19.6) 116 (30.1) 250 (23.4)
  Missing 6 (0.9) 1 (0.3) 7 (0.7)
Sex
  Male 366 (53.6) 179 (46.5) 545 (51.0)
  Female 317 (46.4) 206 (53.5) 523 (49.0)
Total 683 (64.0) 385 (36.0) 1068 (100.0)
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more types of antibiotics (Table  2). The most common 
clinical diagnosis were “respiratory tract infection”(31%), 
“bronchitis/tracheitis” (23%), “pharyngitis”(11%), “com-
mon cold”(8%), “pneumonia/bronchopneumonia” (5%) 
and “tonsillitis”(4%). Patients diagnosed with “bronchitis/
tracheitis” witnessed the highest antibiotics prescription 
rate (94%), followed by “tonsillitis” (93), “pneumonia/
bronchopneumonia” (91%) and “respiratory tract infec-
tion” (90%). Prescription of multiple (2 or more) anti-
biotics happened most frequently for COPD (76%), 
bronchitis/tracheitis (50%), tonsillitis (50%) and pneumo-
nia/ bronchopneumonia (46%) patients. The most com-
monly used antibiotics were penicillins, cephalosporins 
and quinolones. In terms of the anatomical therapeutic 
chemical (ATC) classification, J01MA12 ranked the high-
est (31% in all the patients studied), followed by J01CA04 
(15%), J01FA13 (15%), J01CR02 (15%) and J01DC02 
(10%) (Additional file 1).
Diagnosis and bacteria identification
Of all the specimens tested, 329 (31%) were isolated with 
pathogenic bacteria or asymptomatic carrier, and 23 of 
them, with two strains of bacteria. These 352 isolates 
comprised 85 (24%) for K. pneumonia, 57 (16%) for H. 
influenzae, 52(15%) for H. parainfluenzae, 22(6%) for P. 
aeruginosa, 18 (5%) for S.aureus, 12 (3%) for M. catarrh-
alis, 8 (2%) for S. pneumoniae, 6 (1%) for β.haemolytic 
streptococci, 5(1%) for A.baumannii and 4(1%) for E.coli. 
The study did not find statistically significant difference 
in the chances of bacteria isolation between patients with 
different clinical diagnosis. Table  3 provides bacterial 
detection results from sputum and throat swab speci-
mens by diagnosis; while the results from sputum and 
throat swab specimens are given separately in Additional 
files 2 and 3.
Antibiotics prescription and bacteria sensitivity
Figure 1 portraits the prescription rate of specific anti-
biotics and resistance rate of the top 5 bacteria iso-
lated from sputum and swab specimens. These bacteria 
were tested sensitive to most of the antibiotics stud-
ied. The highest resistance rate was estimated as 97.4% 
for K. pneumoniae to Ampicillin followed by 92.3 for 
S. aureus to Penicillin and 62.3% for H.influenzae to 
Sulfamethoxazole. No clear association between the 
frequency of antibiotics prescription and the rates of 
resistance was observable. The highest resistance rate 




This study reveals useful findings on antibiotic use and 
microbiological test results for patients presenting RTIs 
symptoms at rural and township care settings in Anhui, 
China. It documents an antibiotic prescription rate as 
high as 87.8% and most frequent use of broad-spectrum 
and multiple antibiotics. It demonstrates that nearly one 
third (30.8%) of the specimens were isolated with path-
ogenic bacteria or asymptomatic carrier with the top 
bacteria strains being K. pneumonia, H. influenza, H. 
parainfluenzae, P. aeruginosa and S. aureus and the high-
est resistance rate being K. pneumoniae to ampicillin fol-
lowed by S.pneumoniae to Clindamycin, H. influenzae to 
Trimethoprim/ Sulfaisoxazole and H. parainfluenzae to 
Ampicillin.
Table 2 Antibiotic use by clinical diagnosis, N (%) 
Patients Any antibiotic Number of antibiotics used Category of antibiotics used
1 2 3 + Quinolones Cephalosporins Penicillins Others
Diagnosis
  -Respiratory tract infection 326 (30.5) 296 (90.8) 179 (54.9) 92 (28.2) 24 (7.4) 112 (34.4) 92 (28.2) 141 (43.3) 22 (6.7)
  -Bronchitis/tracheitis 249 (23.3) 234 (94.0) 109 (43.8) 101 (40.6) 23 (9.2) 106 (42.6) 82 (32.9) 109 (43.8) 7 (2.8)
  -Pharyngitis 119 (11.1) 104 (87.4) 84 (70.6) 15 (12.6) 4 (3.4) 17 (14.3) 20 (16.8) 54 (45.4) 10 (8.4)
  -Common cold 85 (8.0) 69 (81.2) 57 (67.1) 7 (8.2) 5 (5.9) 12 (14.1) 50 (58.8) 11 (12.9) 5 (5.9)
  -Pneumonia/bronchopneu-
monia
48 (4.5) 44 (91.7) 22 (45.8) 16 (33.3) 6 (12.5) 16 (33.3) 25 (52.1) 17 (35.4) 2 (4.2)
  -Tonsillitis 44 (4.1) 41 (93.2) 19 (43.2) 15 (34.1) 7 (15.9) 18 (40.9) 17 (38.6) 18 (40.9) 1 (2.3)
  -COPD 29 (2.7) 26 (89.7) 4 (13.8) 15 (51.7) 7 (24.1) 20 (69.0) 7 (24.1) 17 (58.6) 0 (0.0)
  -Others 24 (2.2) 15 (62.5) 11 (45.8) 4 (16.7) 0 (0.0) 4 (16.7) 7 (29.2) 5 (20.8) 1 (4.2)
  -Diagnosis not given 144 (13.5) 109 (75.7) 71 (49.3) 31 (21.5) 7 (4.9) 30 (20.8) 59 (41.0) 32 (22.2) 15 (10.4)
P 0.000 0.000 0.000 0.002 0.000 0.000 0.000 0.015
Total 1068 (100) 938 (87.8) 556 (52.1) 296 (27.7) 86 (8.1) 335 (31.4) 359 (33.6) 404 (37.8) 63 (5.9)





































































































































































































































































































































































































































































































































































































































































































Page 6 of 9Shen et al. BMC Fam Pract           (2021) 22:87 
Implications in context of other research and for policy
The above study findings have important implications 
for antibiotics stewardship. The high rate of antibiot-
ics prescriptions contradicts a common belief among 
policymakers in China that excessive antibiotics use is 
being brought under control as a result of the nation-
wide Special Antibiotics Use Rectification program 
(initiated in 2011) and the New Health System Reforms 
[19, 20]. These initiatives focus on antibiotics use at 
secondary and tertiary hospitals. Given that about 57% 
of China’s vast population lives in rural and township 
areas and over 70% of antibiotics prescriptions occur 
at settings in these areas [21, 22], there is a clear need 
for added attention on excessive antibiotics use at these 
settings and communities.
The frequent use of broad-spectrum and multiple 
(2 or more) antibiotics calls for stewardship programs 
aiming at not only reducing the number of prescriptions 
but also promoting single and narrow-spectrum anti-
biotics. Most of the broad-spectrum antibiotics, espe-
cially quinolones, cephalosporins and amoxi-clav, have 
strong resistance driving effect; while use of multiple 
antibiotics often acts as an even greater driver. This 
prevalent use of broad-spectrum and multiple antibi-
otics may be attributed mainly to medical uncertainty 
though decisions on which specific antibiotics to use 
depends on a variety of factors including availability, 
price, sensitivity, adverse effects and other characteris-
tics of the antibiotics under concern [23–27]. Rural and 
township healthcare doctors in China work in a difficult 
situation in which microbiological tests are unavailable 
and it is hard to tell the pathogen and its sensitivity to 
specific antibiotics from clinical symptoms/ history. So, 
they tend to view broad-spectrum or combined antibi-
otics as a safer strategy than narrow spectrum antibiot-
ics since the former have greater chance of hitting the 
actual pathogen [28, 29].
The microbiological test results indicate the feasi-
bility of such tests for rural and township care attend-
ees in resource-poor rural China. As described in our 
separate protocol paper, the testing proceeded by col-
lecting specimens at the rural and township care set-
tings and sending the specimens to a tertiary hospital 
with a microbiological lab via existing transportation 
Fig. 1 Antibiotics prescription rates compared with antibiotics resistance rates (grey bars represent not applicable or not performed tests)
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services [14]. We collected and tested 1068 specimens 
out of 1073 RTI patients. Our overall rate of bacte-
ria detection was 30.8% which is compatible with 
published results for similar population groups [30]. 
These all suggest that the testing is acceptable to both 
patients and physicians and the test results are rela-
tively reliable.
The difference between the resistance rates tested 
in this study and that from higher level settings sug-
gests a need for incorporating rural and township 
care settings into China’s national antibiotics use 
and resistance surveillance systems. Our study indi-
cates that antibiotics resistance rates among rural 
and township care attendees are substantially lower 
than that among patients of hospitals forming the 
national antibiotics resistance surveillance network, 
being 2.5% vs 56.6% for K.pneumonia to cefazolin, 
58.0% vs 60.3% for H.influenzae to ampicillin, 5.9% vs 
25.2% for P.aeruginosa to piperacillin, 35.3% vs 61.5% 
for S.aureus to erythromycin and 80.0% vs 89.9% for 
S.pneumoniae to clindamycin [30]. These differences 
in resistance between hospitals and primary care 
would imply lower general antibiotics prescribing, and 
especially more narrow-spectrum antibiotics. How-
ever, as mentioned above, doctors at primary care set-
tings are practicing the opposite.
The early healthcare seeking together with the high 
rate of antibiotics prescription highlights the impor-
tance of educating doctors and patients to postpone 
antibiotics prescription and use. The study found 
that over 60% of visits to the village clinics or health 
centers happened within 4  days after onset of infec-
tion symptoms and the mean time of visits was 6 days. 
This is relatively short as compared to that from 
western nations. Studies from Europe of lower RTIs 
have documented a mean time lag of 4 to 12  days 
[31]. Early visits to clinics with a clear expectation 
to get antibiotics merits adequate attention in future 
interventions.
Both the profiles of detectable pathogen and asymp-
tomatic carrier bacteria have important implica-
tions. Detection of pathogen bacteria (e.g., S.aureus, 
M.catarrhalis, S.pneumoniae,βhaemolytic streptococci 
and E.coli) should inform clinical treatment decision-
making. Although detection of the asymptomatic carrier 
may not necessarily cause the infections, it may be used 
as indirect or surrogate indicators for assessing antibiotic 
resistance. Perhaps the biggest barrier to microbiological 
evidence-based antibiotics use for primary care doctors 
at present may be the delay due to sending specimens 
to and getting results from higher level labs in addition 
to time needed for bacteria cultivation and test. Point of 
care tests may help overcome this barrier. Unfortunately, 
such tests are generally not available in China [32]. This 
lack of external validity and clinical uncertainty in pri-
mary care together with the links between antibiotics 
prescription and the number of days until care seeking 
call for more patient education and more use of a delayed 
prescribing strategy.
Strengths and limitations of the study
This study has both strengths and limitations. It is the 
first study that collected data from healthcare pro-
viders and users via a non-participative observation 
whilst most of the existent research on antibiotics use 
in China uses data from medical records or reports by 
medical care givers who may be incentivized to omit 
recording overuse or misuse of antibiotics so as to meet 
relevant policy requirements. It is also the first study 
that performed both microbiological testing and clini-
cal data collection at rural and township care settings 
and thus enables cross-linking between data from dif-
ferent sources. However, the study suffers from limited 
number of patients and site clinics. It involved only 
8 site clinics or health centers from a single province. 
So, readers are cautioned about the generalization of 
the findings to other parts of China, thought the social, 
cultural and economic background of Anhui is similar 
to the majority of areas in the nation. The non-partic-
ipative observation may also have intervened, to some 
extent, the routine encounters between the patients and 
doctors and the prescription behaviors being observed 
though we had arranged a two-week preparation for 
each site clinic to allow the field researchers to build 
trust with the doctors. The paper tried to use pure clini-
cal diagnoses to evaluate the other findings; while in 
reality, it is generally hard to separate the diagnoses of 
respiratory tract infection and common cold, further-
more pharyngitis and tonsillitis.
Conclusions
The study makes innovative use of observations in 
collecting data about antibiotics prescription at rural 
and township care settings in China for patients with 
respiratory tract infections and establishes the feasi-
bility of conducting microbiological testing outside 
Tier 2 and 3 hospitals in rural China. It reveals that 
prescription of antibiotics, especially broad-spectrum 
and combined antibiotics, is still very common in 
rural China and there is a clear need for stewardship 
programs aimed at both reducing the number of pre-
scriptions and promoting single and narrow-spectrum 
antibiotics. It also documents important differences 
in resistance between hospitals and primary care and 
calls for new specific guidelines for primary care based 
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on findings from this and other papers and interna-
tional expertise like that from the General Practice 
Respiratory Infections Network.
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